Original Source(s)
Related Content
First MCT8 deficiency therapy approved
Clinical studies showed reductions in circulating thyroid hormone levels and changes in heart rate and systolic blood pressure.
September 29, 2026
-
3 min
FDA expands treatment in nephrotic syndrome
The indication marks an additional use for a therapy previously approved for certain cancers and active lupus nephritis.
September 28, 2026
-
2 min